NCT06301360

Brief Summary

Functional somatic syndromes (e.g. irritable bowel syndrome, fibromyalgia) and medically unexplained symptoms (e.g. chronic primary pain) are very common in primary care. These patients make 14 times more doctor visits than the general population, but describe themselves as less satisfied with the care they receive. Although Region Stockholm in Sweden recently developed care flows based on 'step up' care for the most common patient groups in primary care, patients with functional or medically unexplained symptoms are not mentioned. Short-term psychodynamic therapies such as Emotional Awareness and Expression Therapy (EAET) and Intensive Short Term Psychodynamic Therapy (ISTDP) have recently been evaluated in three systematic reviews and show good results for patients with medically unexplained symptoms. Short-term psychodynamic therapy considers that good treatment outcomes for patients with functional somatic syndromes can be achieved by increasing awareness of emotions and teaching patients to better experience, express and regulate emotions. In several randomized studies, short-term psychodynamic therapy has shown good effects even compared to other treatments, including cognitive behavioral therapy (CBT). The overall purpose of this research project is to to evaluate psychodynamic emotion-focused interventions (EAET and ISTDP) for patients with medically unexplained symptoms/functional somatic symptoms (MUS/FSD). The project includes several studies that will clarify effects and contribute to information on how care flows in primary care for the patient group can be created. The research question for this specific study is: Is internet-based Emotional Awareness and Expression Therapy (I-EAET) with therapist more effective than without therapist support for patients with FSD?

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 27, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 8, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

1.5 years

First QC Date

February 27, 2024

Last Update Submit

March 8, 2024

Conditions

Keywords

Internet based interventionsEAETPsychodynamic therapy

Outcome Measures

Primary Outcomes (2)

  • Patient Health Questionnaire -15 (PHQ-15)

    Ratings 0-2 on how troublesome somatic symptoms are experienced. Higher scores indicates worse symptom/functioning.

    Change from pre to post treatment (after 10 weeks of treatment)

  • Numeric Rating Scales according to EURONET-SOMA

    Visual analogue scale 0-10 for symptom intensity and symptom interference. Higher scores indicates worse symptom/functioning.

    Change from pre to post treatment (after 10 weeks of treatment)

Secondary Outcomes (6)

  • Generalized Anxiety Disorder-7 (GAD-7)

    Change from pre to post treatment (after 10 weeks of treatment)

  • Patient Health Questionnaire-9 (PHQ-9)

    Change from pre to post treatment (after 10 weeks of treatment)

  • Post traumatic stress disorder checklist-5 (PCL-5)

    Change from pre to post treatment (after 10 weeks of treatment)

  • Difficulties in Emotion Regulation Scale-16 (DERS-16)

    Change from pre to post treatment (after 10 weeks of treatment)

  • Sheehan Disability Scale (SDS)

    Change from pre to post treatment (after 10 weeks of treatment)

  • +1 more secondary outcomes

Other Outcomes (3)

  • Mediational measure: DERS-16

    Each week once a week throughout 10 weeks of treatment

  • Mediational measure: PHQ-15

    Each week once a week throughout 10 weeks of treatment

  • Mediational measure: PHQ-4

    Each week once a week throughout 10 weeks of treatment

Study Arms (2)

I-EAET with therapist support

EXPERIMENTAL

I-EAET is a 10 week treatment intervention combining principles from emotion focused therapies and neuroscience. Main components include psychoeducation on the body-mind connection, anxiety regulation with self-compassion exercises and different techniques for emotional exposure and processing. Participants have help from a therapist giving feedback.

Behavioral: Internet based Emotional Awareness and Expression Therapy (I-EAET)

I-EAET without therapist support

ACTIVE COMPARATOR

I-EAET is a 10 week treatment intervention combining principles from emotion focused therapies and neuroscience. Main components include psychoeducation on the body-mind connection, anxiety regulation with self-compassion exercises and different techniques for emotional exposure and processing. Participants works on their own and have only technical support.

Behavioral: Internet based Emotional Awareness and Expression Therapy (I-EAET)

Interventions

In I-EAET with therapist support, the therapist and participants communicate asynchronous using written messages. The therapist gives feedback each week on home-work assignments and is available on demand for support. In I-EAET without therapist support, the participants works with home-work assignments on their own and only have technical support.

I-EAET with therapist supportI-EAET without therapist support

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The research subject certifies that he/she has undergone medical assessment for his/her physical symptoms.
  • The subject rates either moderate distress from bodily symptoms in the PHQ-15 (over 10 points) or severe distress from a single bodily symptom (at least 2 points for this symptom).
  • The research participants expresses interest in investigating whether emotional factors such as stress may contribute to symptoms.
  • Research subjects either affirm the presence of emotionally difficult life events (affirm at least 1 such event in the Adverse Childhood Experience (ACE-10) or reach the proposed cut-off point of 23p in the PCL-5).
  • Drugs used should have been stable for at least 1 month.

You may not qualify if:

  • Research subjects suffer from ongoing substance abuse (alcohol or drugs) or are deemed to have serious mental illness (psychotic illness, suicidal ideation, antisocial personality disorder etc).
  • The research subjects have ongoing medication of a clearly addictive and sedative nature (e.g. benzodiazepines).
  • The research subject participates in other psychological treatment focusing on physical symptoms. However, other psychological treatment is allowed where the support therapy does not take place more often than once a month.
  • The research subject does not master the Swedish language sufficiently to be able to assimilate written material in Swedish.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Stockholm University

Stockholm, 10691, Sweden

RECRUITING

Stockholm University

Stockholm, 11419, Sweden

RECRUITING

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: RCT with two treatment arms
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD, principal investigator

Study Record Dates

First Submitted

February 27, 2024

First Posted

March 8, 2024

Study Start

December 1, 2023

Primary Completion

June 1, 2025

Study Completion

December 31, 2025

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Original data shared on demand from other researchers and after approval from Swedish Ethical Review Authority.

Locations